Bill Amendment: TX HB1586 | 2021-2022 | 87th Legislature
NOTE: For additional amemendments please see the Bill Drafting List
Bill Title: Relating to health benefit plan coverage of clinician-administered drugs.
Status: 2021-05-17 - Referred to Business & Commerce [HB1586 Detail]
Download: Texas-2021-HB1586-House_Amendment_H_2_1-Lucio_III.html
Bill Title: Relating to health benefit plan coverage of clinician-administered drugs.
Status: 2021-05-17 - Referred to Business & Commerce [HB1586 Detail]
Download: Texas-2021-HB1586-House_Amendment_H_2_1-Lucio_III.html
Amend CSHB 1586 (house committee report) by striking page 3, line 24, through page 4, line 5, and substituting the following:
Sec. 1369.553. CERTAIN LIMITATIONS ON COVERAGE OF CLINICIAN-ADMINISTERED DRUGS PROHIBITED. (a) A health benefit plan issuer may not, for a patient with a chronic, complex, rare, or life-threatening medical condition:
(1) require a clinician-administered drug to be dispensed by a pharmacy selected by the health benefit plan issuer;
(2) require that a clinician-administered drug or the administration of a clinician-administered drug be covered as a pharmacy benefit rather than a medical benefit;
(3) if a clinician-administered drug is otherwise covered, limit or exclude coverage for the clinician-administered drug when not dispensed by a pharmacy selected by the health benefit plan issuer; or
(4) prohibit a physician or health care provider from obtaining or administering a clinician-administered drug that the physician or provider is otherwise permitted to obtain or administer by law.